Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
12/2008
12/04/2008WO2008145225A2 Photocrosslinkable materials comprising alicyclic group
12/04/2008US20080300308 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
12/04/2008US20080300287 Peptidic Compounds
12/03/2008CN101316509A Compounds and relative use for the control of phytopathogens
12/02/2008US7459582 Methods for producing nateglinide crystals
12/02/2008US7459581 and fungicide; antiprespirant; hydroxy-acetic acid 2-ethyl-hexyl ester; odourless; reasonable residence time on the skin; household products, cosmetic and personal care products
12/02/2008US7459580 Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives
12/02/2008CA2221278C Process for the preparation of 5-amino-2,4,6-triiodoisophthalic acid dichloride by chlorination with thionyl chloride in the presence of a catalyst
11/2008
11/27/2008WO2008143339A1 Amphipathic molecule, molecular aggregate comprising the amphipathic molecule, and use of the molecular aggregate
11/27/2008US20080294289 Preparation and Use of Alkylating Agents
11/27/2008US20080293939 Quinazolinone derivatives useful as anti-hyperalgesic agents
11/27/2008US20080293920 Arginine Analogs, and Methods for Their Synthesis and Use
11/27/2008US20080293813 Compositions and Methods
11/27/2008US20080293812 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
11/27/2008US20080293810 Multi-dose concentrate esmolol with benzyl alcohol
11/27/2008US20080293728 Complexes Comprising alpha2-Adrenergic Receptor Agonists and Compositions
11/27/2008US20080293695 Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
11/27/2008US20080293680 Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II
11/27/2008US20080293678 Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use
11/27/2008US20080292558 Colored esmolol concentrate
11/27/2008US20080292552 Pet Radiotracers
11/26/2008EP1995250A1 Ligand, method for producing the same, and catalyst using the ligand
11/26/2008EP1594492B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/26/2008EP1506162B1 Synthesis of benzonitriles and benzimidates
11/26/2008CN101312939A Heterocyclic cetp inhibitors
11/26/2008CN101311151A Process for the preparation of 3,3-dimethylbutanal
11/26/2008CN100436429C Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof
11/26/2008CN100436408C Material and intermediate for trifluoromethyl-substituted spirocyclic ketoenols
11/26/2008CN100436386C Improved metal-ligand complex catalyzed processes
11/25/2008US7456312 making gabapentin tannate to treat central nervous system disorders by reacting gabapentin and tannic acid; used in sustained release applications and to improve certain organoleptic properties such as taste
11/25/2008US7456217 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of multiple sclerosis
11/25/2008US7456216 Methods for the preparation and formulation of l-carnitine valproate salts
11/20/2008WO2008140023A1 METHOD FOR PRECIPITATING α-CRYSTALS OF GLUTAMIC ACID
11/20/2008WO2008139539A1 Process for producing valacyclovir
11/20/2008WO2008139080A1 Method for the co-production of non-cyclic carbonates and amino acids
11/20/2008WO2008138961A1 Method for producing vinyl esters of carboxylic acids
11/20/2008WO2008138874A1 Process for preparing (s)-pregabalin by optical resolution of racemic pregabalin
11/20/2008WO2008138621A2 Synthesis of aminocyclopentane carboxylic acids
11/20/2008US20080287687 Production method of diphenylalanine-Ni (II) complex
11/20/2008US20080287537 Composition, Particularly a Cosmetic Composition, Comprising ((Dialkylamino)Alkoxy) Ethanol Ester
11/20/2008US20080287441 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
11/20/2008US20080287344 Use of Amino Acids for Making Medicines for Treating Insulin Resistance
11/19/2008EP1992610A1 New route of synthesis
11/19/2008EP1992609A1 A process for the preparation of a (S)(+)-3-(aminomethyl)-5-methylhexanoic acid
11/19/2008EP1992607A1 Method for producing 4-oxoquinoline compound
11/19/2008EP1991522A2 Deuterated catecholamine derivatives and medicaments comprising said compounds
11/18/2008US7452995 Aryl aniline β2 adrenergic receptor agonists
11/18/2008US7452878 Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/18/2008US7452874 Thrombopoietin mimetics
11/18/2008CA2393655C Method for the preparation of enantiomerically enriched compounds
11/18/2008CA2305802C Amide derivatives or salts thereof
11/18/2008CA2219150C Method of making (s)-3-(aminomethyl)-5-methylhexanoic acid
11/14/2008CA2631110A1 A process for the preparation of (s)(+)-3-(aminomethyl)-5-methylhexanoic acid
11/13/2008WO2008137512A2 Process for preparing pregabalin via hofmann reaction and crystalline form thereof
11/13/2008WO2008134937A1 A process for producing the ctystal of glutamic acid
11/13/2008WO2008134936A1 Method for extracting threonine from threonine fermentation liquor
11/13/2008WO2007079394A3 Arginine heteromers for topical administration
11/13/2008US20080281123 Method for Producing Theanine
11/13/2008US20080281074 Delivering nucleic acids to cells; complexing nucleic acid with polyampholte; contacting cell; biocompatible in vivo delivery; gene therapy
11/13/2008US20080280982 3-{4-[1-(4'-tert-Butyl-biphenyl-4-ylmethyl)-3-methyl-butyl]-benzoylamino}-propionic acid, used as hypoglycemic agents of for the treatment of metabolic disorders such as diabetes
11/13/2008DE10248022B4 Verwendung chelatisierter Pflanzenspurennährstoffe Use of chelated trace nutrients plants
11/12/2008CN101302178A Production process of L-cystine
11/12/2008CN101302171A Production process of pure amino acid chelate and use thereof
11/12/2008CN100432060C Process for producing benzoxazine derivative and production intermediate thereof
11/12/2008CN100432059C Quinazolinone derivatives useful as anti-hyperalgesic agents
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/11/2008US7449495 e.g. 4-(3-(1-Adamantyl)-4-tert-butyldimethyl-silyloxyphenyl)benzaldehyde; antitumor, antiinflammatory agent; arthritic pathology, metastatisation, diabetic retinopathy, psoriasis, chronic inflammatory disease, and atherosclerosis; sarcoma, carcinoma, carcinoid, leukaemia
11/11/2008US7449198 Stable salts of O-acetylsalicylic acid with basic amino acids
11/06/2008WO2008033365A3 Amino ion releasing hydrogen bonded molecule
11/06/2008US20080275216 Fluorous Capping Reagents and Methods for Peptide Purification
11/06/2008US20080275112 3-Aminoadamantane-1-carboxylic acid derivatives in which position 5 or 7 of the adamantane skeleton has been optionally substituted; coupling of monomeric amino acid derivatives to oligomers; antiviral agents GABA analogues, oligopeptides, ion channel modulators, and peptidic catalysts
11/06/2008US20080275087 Biphenylcarboxamides useful as lipid lowering agents
11/06/2008US20080274888 N-Acetylcysteine Amide (Nac Amide) for Enhancing Plant Resistance and Tolerance to Environmental Stress
11/05/2008EP1988066A2 Binding of fibrous material utilizing a crosslinked polyamic acid
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008CN101300224A Process for making (s)-pregabalin
11/05/2008CN101298423A Extraction method of valine
11/05/2008CN101298422A Extraction method of L-isoleucine
11/04/2008US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation
11/04/2008US7446128 Agent for treating interstitial cystitis
10/2008
10/30/2008WO2008129873A1 Phenylalanine aminomutase with selectivity for s-form, dna encoding the same, method for producing (s)-β-phenylalanine and method for producing (s)-β-phenylalanine analogs
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008US20080269108 Crystalline forms of the Di-Sodium Salt of N-(5-Chlorosalicyloyl)-8-Aminocaprylic Acid
10/30/2008US20080268519 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
10/30/2008US20080268518 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses
10/29/2008EP1984380A1 Process to prepare metal complex of n,n-bis(2-hydroxyethyl)glycine
10/29/2008CN101293867A Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
10/29/2008CN101293850A Method for preparing 3-N,N-dimethylamino-ethyl acrylate
10/29/2008CN101293849A Process for preparing glutamic acid crystallization
10/29/2008CN101293848A Glutamic acid extracting technique
10/29/2008CN101293847A Method for extracting threonine with threonine fermentation liquor
10/29/2008CN101293846A Method for preparing ethylene diamine triacetate
10/28/2008US7442834 treating cyclohexane 1,1-diacetic acid monoamide with sodium hydroxide and sodium hypochlorite to form 3,3-pentamethylenebutyrolactam, which is then hydrolzed with hydrochloric acid to a gabapentin salt, followed by neutralization and dehydration to 1-(aminomethyl)-1-cyclohexaneacetic acid
10/28/2008US7442833 e.g. (2E)-3-(4-{(1Z)-2-phenyl-1-[4-(propionyloxy)phenyl]but-1-enyl}phenyl)prop-2-enoic acid; postmenopausal disorders, depressive symptoms; acylating anisole with 2-phenylbutanoic acid followed by demethylation, dehydration to yield phenol aldehyde, acylation and carboxylation to yield ester prodrug
10/28/2008US7442830 Proteasome inhibitors
10/28/2008US7442829 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
10/28/2008US7442808 e.g. 3-(indan-1-yloxy)-8-(oxazolidin-2,4-dion-5-yl)-5,6,7,8-tetrahydroquinoline; with other active ingredients; agonists of G-protein coupled receptor 40 (GPR40); antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity, hyperlipemia
10/28/2008US7442796 oxo-acids such as [3-(2,6-Dimethylbenzyloxy)-phenyl]-oxoacetic acid, used for treating insulin resistance, diabetes, hyperlipemia, liver disorders, cachexia, obesity, atherosclerosis and arteriosclerosis
10/28/2008CA2152979C Poly-perfluoroalkyl-substituted alcohols and acids, and derivatives thereof
10/23/2008WO2008104722A3 Method for the synthesis of omega-amino-alkanoic acids
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 215